相关实验视频

Updated: May 28, 2025

Immunophenotyping of Orthotopic Homograft Syngeneic of Murine Primary KPC Pancreatic Ductal Adenocarcinoma by Flow Cytometry

Immunophenotyping of Orthotopic Homograft Syngeneic of Murine Primary KPC Pancreatic Ductal Adenocarcinoma by Flow Cytometry

Published on: October 9, 2018

葡萄糖科学在推进PD-1/PD-L1-轴向瘤免疫疗法中的作用

Qiyue Sun¹, Senlian Hong¹

¹State Key Laboratory of Natural and Biomimetic Drugs, Chemical Biology Center, Department of Chemical Biology, School of Pharmaceutical Sciences, Peking University, Beijing 100191, China.

International journal of molecular sciences

|February 13, 2025

概括

糖化对癌症的免疫规避和免疫疗法反应产生影响. 葡萄糖科学的进步,或葡萄糖疗法,增强PD-1/PD-L1阻断治疗,以改善癌症患者的治疗结果.

科学领域:

免疫学免疫学免疫学
在瘤学瘤学.
葡萄糖科学 (Glycoscience) 是一种科学.

背景情况:

使用抗PD-1/PD-L1抗体的免疫检查点阻塞 (ICB) 疗法彻底改变了癌症治疗.
然而,局限性包括低响应率,与免疫相关的不良影响和耐药性.
异常的糖基化被越来越多地认为是癌症进展和免疫规避的关键因素.

研究的目的:

审查糖化在PD-1/PD-L1轴中的作用.
突出糖科学 (糖疗法) 的进步,以提高ICB的疗效.
探索针对癌症的个性化医疗策略,以糖化为目标.

主要方法:

关于糖化,PD-1/PD-L1和免疫疗法研究的文献综述.
对糖疗法和糖基工程领域最近取得的成就进行分析.
讨论针对癌症特异性糖基化模式的治疗策略.

主要成果:

PD-1和PD-L1蛋白质具有高度的糖化,影响它们的相互作用和抗体结合.
糖基工程抗体对PD-1/PD-L1.1具有更好的结合亲和力.
核心基化和基化抑制剂,以及抗体-基酶结合剂显示出治疗潜力.

结论:

针对异常的癌症糖基化,为精准医学提供了一个有前途的途径.
糖疗是一种强大的策略,可以提高PD-1/PD-L1阻断疗法的有效性.
葡萄糖科学的进步对于克服癌症免疫治疗当前的局限性至关重要.

关键词:

在PD-1/PD-L1阻塞中.葡萄糖酶化是什么? 葡萄糖酶化是什么?免疫疗法免疫疗法

更多相关视频

Identifying PD-1/PD-L1 Inhibitors with Surface Plasmon Resonance Technology

Identifying PD-1/PD-L1 Inhibitors with Surface Plasmon Resonance Technology

Published on: May 2, 2025

Monitoring PD-1-Blocking Antibodies Bound to T Cells Derived from a Drop of Peripheral Blood

Monitoring PD-1-Blocking Antibodies Bound to T Cells Derived from a Drop of Peripheral Blood

Published on: February 5, 2020

相关概念视频

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Protein Glycosylation

Protein Glycosylation

Glycosylation, the most common post-translational modification for proteins, serves diverse functions. Adding sugars to proteins makes the proteins more resistant to proteolytic digestion. Glycosylated proteins can act as markers and receptors to promote cell-cell adhesion. Additionally, they have many essential quality control functions in the cell, such as correct protein folding and facilitating transport of misfolded proteins to the cytosol, which can be degraded.
Glycosylation occurs in...